Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEquity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pharming (PHAR) Non Operating Income (2020 - 2023)

Historic Non Operating Income for Pharming (PHAR) over the last 4 years, with Q3 2025 value amounting to $1.7 million.

  • Pharming's Non Operating Income rose 17973.98% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.8 million, marking a year-over-year decrease of 13156.77%. This contributed to the annual value of $1.9 million for FY2024, which is 12981.38% up from last year.
  • According to the latest figures from Q3 2025, Pharming's Non Operating Income is $1.7 million, which was up 17973.98% from -$8.5 million recorded in Q2 2025.
  • Pharming's Non Operating Income's 5-year high stood at $3.6 million during Q2 2024, with a 5-year trough of -$8.5 million in Q2 2025.
  • Over the past 4 years, Pharming's median Non Operating Income value was $6591.0 (recorded in 2021), while the average stood at -$1.6 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first skyrocketed by 18042.65% in 2024, then crashed by 211524.66% in 2025.
  • Pharming's Non Operating Income (Quarter) stood at $6591.0 in 2021, then crashed by 96231.09% to -$6.3 million in 2023, then skyrocketed by 107.23% to $458000.0 in 2024, then soared by 274.67% to $1.7 million in 2025.
  • Its Non Operating Income stands at $1.7 million for Q3 2025, versus -$8.5 million for Q2 2025 and -$4.5 million for Q1 2025.